FIELD: medicine.
SUBSTANCE: invention is intended to assess the safety of a biomedical cell product (BMCP). Control quantitative values are established that characterize the level of telomerase activity in cells with different tumourigenic potential. The levels of telomerase activity in the controls are compared. An evaluation of the safety of the test cells used for the production of BMCP or cells within the BMCP is conducted.
EFFECT: increased accuracy due to the use of experimentally established control quantitative parameters - the level of telomerase activity in cells with different tumourigenic potential.
2 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTION OF TUMOURIGENIC CELLS IN PRIMARY CULTURE OF HUMAN FIBROBLASTS | 2021 |
|
RU2792061C1 |
| METHOD FOR PREDICTING GROWTH RATE OF CULTURE BY AMOUNT OF ALDEHYDE DEHYDROGENASE-POSITIVE BONE MARROW MESENCHYMAL CELLS OF DONORS | 2019 |
|
RU2722173C1 |
| SPECIALISED MEDIUM FOR HUMAN AMNIOTIC FLUID AND FIBROBLAST CELL CULTURE | 2009 |
|
RU2415929C2 |
| METHOD FOR PRODUCING MESENCHYMAL STEM CELLS OF HUMAN PLURIPOTENT STEM CELLS, AND MESENCHYMAL STEM CELLS PRODUCED BY THIS METHOD | 2009 |
|
RU2528250C2 |
| METHOD FOR ASSESSING DIFFERENTIATION OF MESENCHYMAL STEM CELLS IN THREE-DIMENSIONAL SCAFFOLDS | 2023 |
|
RU2818354C1 |
| COMPOUNDS, COMPOSITIONS, METHODS AND SETS RELATED TO TELOMERE ELONGATION | 2014 |
|
RU2766120C2 |
| METHOD FOR EVALUATING AND MONITORING IN VITRO PURITY OF A CELL PREPARATION, USE OF A GROWTH FACTOR, A KIT | 2016 |
|
RU2738969C2 |
| METHOD OF INCREMENT IN RETINA CAPACITY WITH VARIOUS PATHOLOGIES | 2008 |
|
RU2364382C1 |
| COSMETIC MEANS ON THE BASIS OF SECRECTION PRODUCTS OF MESENCHEMICAL STEM/STORMAL CELLS OF FATTY FABRIC OF HUMAN AND THE METHOD OF ITS PRODUCTION | 2016 |
|
RU2620342C1 |
| BIOMEDICAL CELL PRODUCT, METHOD FOR ITS PRODUCTION AND APPLICATION | 2018 |
|
RU2741769C2 |
